Prelude Therapeutics Cash from Investing (TTM) Trends

Prelude Therapeutics Inc (PRLD)

4.12 -0.03 (-0.72%) USD | NASDAQ | Apr 18, 10:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-34.65M
September 30, 2023	-41.03M
June 30, 2023	-34.46M
March 31, 2023	58.14M
December 31, 2022	81.69M
September 30, 2022	78.53M
June 30, 2022	-203.71M

Date	Value
March 31, 2022	-221.27M
December 31, 2021	-263.80M
September 30, 2021	-262.33M
June 30, 2021	-1.866M
March 31, 2021	-1.527M
December 31, 2020	-0.621M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-263.80M

Minimum

Dec 2021

81.69M

Maximum

Dec 2022

-65.15M

Average

-34.46M

Median

Jun 2023

Cash from Investing (TTM) Benchmarks